Express Implant Versus Trabeculectomy After Late Failure Trabeculectomy

Condition:   Glaucoma Intervention:   Procedure: Express implant device Sponsor:   Menoufia University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials

Related Links:

Condition:   Glaucoma Interventions:   Device: Baerveldt 350 implant;   Device: Ahmed ClearPath 350 implant Sponsor:   Duke University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
DISCUSSION: To the best of our knowledge, this is the first reported case of endocapsular haematoma as a complication of non-penetrating glaucoma surgery that has been successfully solved by a YAG capsulotomy. PMID: 32653318 [PubMed - as supplied by publisher]
Source: Archivos de la Sociedad Espanola de Oftalmologia - Category: Opthalmology Tags: Arch Soc Esp Oftalmol Source Type: research
Publication date: 15 December 2020Source: Chemical Engineering Journal, Volume 402Author(s): Jui-Yang Lai, Li-Jyuan Luo, Duc Dung Nguyen
Source: Chemical Engineering Journal - Category: Chemistry Source Type: research
CONCLUSIONS: Cataract is the most critical complication in children with uveitis at presentation and raised intraocular pressure occurs at follow-up, perhaps attributed to the treatment. Maculopathy is the most common cause of blindness in these children. PMID: 32649841 [PubMed - as supplied by publisher]
Source: Ocular Immunology and Inflammation - Category: Allergy & Immunology Tags: Ocul Immunol Inflamm Source Type: research
Publication date: September 2020Source: Biomedical Signal Processing and Control, Volume 62Author(s): S.J. Grace Shoba, A. Brintha Therese
Source: Biomedical Signal Processing and Control - Category: Biomedical Science Source Type: research
Conditions:   Glaucoma, Primary Open Angle;   Cataract Intervention:   Drug: Intracanalicular Dexamethasone, 0.4 mg insert Sponsor:   Wolstan and Goldberg Eye Associates Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Glaucoma, Open-Angle Intervention:   Device: OMNI® Surgical System Sponsor:   Sight Sciences, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Glaucoma, Primary Open Angle;   Cataract Intervention:   Drug: Intracanalicular Dexamethasone, 0.4 mg insert Sponsor:   Wolstan and Goldberg Eye Associates Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Glaucoma, Open-Angle Intervention:   Device: OMNI® Surgical System Sponsor:   Sight Sciences, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Glaucoma, Primary Open Angle;   Cataract Intervention:   Drug: Intracanalicular Dexamethasone, 0.4 mg insert Sponsor:   Wolstan and Goldberg Eye Associates Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Glaucoma | Men | Research